Clinical uses for calciotropic hormones 1,25dihydroxyvitamin d3 and parathyroid hormonerelated peptide in dermatology: A new perspective

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 1, 1996, Pages 1-9

  Holick, Michael F ^a   Chen, Ming L ^a   Kong, Xiang F ^a   Sanan, Deepak K ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Thyroid hormone antagonist!calcium metabolism; Vsoriasislcalcittotrienelvara

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN; PTHLH PROTEIN, HUMAN;

DRUG RESISTANCE; HUMAN; METABOLISM; PSORIASIS; REVIEW; SUNLIGHT;

CALCITRIOL; CALCIUM; CHOLECALCIFEROL; DRUG RESISTANCE; HUMANS; PARATHYROID HORMONE-RELATED PROTEIN; PROTEINS; PSORIASIS; SUNLIGHT;

EID: 0030112248     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Holick MF: Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang PKT, Schrcibman MP (eds.). Vertebrate Endocrinology; Fundamentals and Biomédical Implications. Vol. 3. Academic Press, Orlando. FL, 1989, pp 7-43
2. Holick MF: McCoIIum Award Lecture, 1994: vitamin D: new horizons for the 21st century. AmJ Clin Nutr 60:619-630, 1994
3. Holick MF, Tian XQ, Allen M: Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci USA 92:3124-3126. 1995
4. Holick MF: Vitamin D: photobiology, metabolism, and clinical applications. In: DeGroot L, ct at (eds.) Endocrinology. 3rd ed. WB Saunders, Philadelphia, 1995, pp 990-1013
5. DeLuca H: The vitamin D story: a collaborative effort of basic science and clinical medicine. Fed Proc Am Soc Exp Biol 2:224-236, 1988
6. Reichcl H, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N EnglJ Med 320:981-991, 1989
7. Stumpf WE, Sar M, Reid FA: Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney skin, pituitary, and parathyroid. Science 206:1188-1190, 1979
8. Abe E, Miyaura C, Sakagami H: Differentiation of rat myc leukemia cells induced by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78:4990-4994, 1981
9. Eisman JA, Suva LJ, Slier E, Pearce PJ, Funder JW, Martin TJ: Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer. Cancer Res 41:5121-5124, 1981
10. Skowronski RJ, Peehl DM, Feldman D: Actions of vitamin D3 analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvïtamïn D3. Endocrinology 136:20-26, 1995
11. Provvedine DM, Tsoukas CD, Deftos LJ, Manolagas SC: lor,25-dihydroxyvitamin Dj-receptors in human leukocytes. Science 221:1181, 1983
12. AdamsJS, Gacad MA, Diz MM, NadlerJL: A role for endogenous archidonate metabolites in regulated expression of the 25-hydroxyvitamïn D-1-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endocrinol Metab 70:595-600, 1990
13. Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ: 1,25(OH)2D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis. J Clin Invest 85:1588-1593, 1990
14. Milde P, Hauser U, Simon T, Mall G, Ernst V, Haussler MR: Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dcrmatol 97:230-239, 1991
15. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T: Regulation of terminal differentiation of cultured mouse epidermal cells by 1,25-dïhydroxyvïtamïn D3. Endocrinology 13:1950-1957, 1983
16. Smith EL, Walworth ND, Holick MF: Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in scrum-free conditions. J Invest Dennatol 86:709-714, 1986
17. MacLaughlin JA, Gange W, Taylor D, Smith E, Holick MF: Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82:5409-5412, 1985
18. Smith EL, Pincus SH, Donovan L, Holick MF: A novel approach for die evaluation and treatment of psoriasis: oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis. J Am Acad Dennatol 19:516-528, 1988
19. Abe J, Kondo S, Nishii Y, Kuroki T: Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. J Clin Endocrinol 68:851-854, 1989
20. Hashimoto K, Matsumoto K, Higashiyama M, Nishïda Y, Yoshikawa K: Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes. BrJ Dennatol 123:93-98, 1990
21. Holick MF: Active vitamin D compounds and analogues: a new therapeutic era for dermatology in the 21st century. Mayo Clin Proc 68:925-927, 1993
22. Perez A, Chen TC, Turner A, Raab R, Bhawan J, Poche P, Holîck MF: Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. BrJ Dennatol (in press)
23. Huckins D, Felson DT, Holick MF: Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study. Arthritis Rlienm 33:1723-1727, 1990
24. Cunliffe WJ, Berth-Jones J. Claudy A, Fairiss G, Goldin D, Gratton D: Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dcnitatol 26:736-743, 1992
25. Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J: Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris: a randomized, double-blind, right/left comparative, vehicle-controlled study. J Am Acad Dennaiol 27:983-988, 1992
26. Langner A, Verjans H, Stapor V, Mol M, Fraczykowksa M: Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. Br J Dermatol 128:566-571, 1993
27. Kragballe K, Gjertsen B, DeHoop D, Karlsmark T, van De Kerkhof P, Larko O: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337:193-196, 1991
28. BourkeJF, Berth-Jones J, Iqbal SJ, Hutchinson PE: High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. BrJ Dermalol 129:74-76, 1993
29. Solvsten H, Svendsen M, Fogh K, Kragballe K: Expression of vitamin D receptor m-RNA and protein in normal and psoriatic skin. In: Norman AW, Bouillon R, Thomasset M (eds.). .lltamin D, a Pliiripotent Steroid Hormone. Walter de Gruyter, Berlin, 1994, pp 592-593
30. Hanafin NM, Persons KS, Holick MF: The mRNA expression of the human 1,25-dihydroxyvitamin D} receptor and c-myc protooncogene in cultured human keratinocytes. In Vitra Cell Den Biol 30A:187-191, 1994
31. Morrison NA, Qi JC, Tokita A, Kelly P, Crofts L, Nguyen T, Sambrook P, Eisman JA: Prediction of bone density from vitamin D receptor allelcs. Nature 367:284-287, 1994
32. Mattin TJ, Moscley JM, Gillespie MT: Parathyroid hormone-related protein: biochemistry and molecular biology. Crit Rev Biochem Mol Biol 26:377-395, 1991
33. Hayman JA, Danks JA, Ebeling PR, Moseley JM, Kemp BE, Martin TJ: Expression of parathyroid hormone-related protein in normal skin and in tumours of skin and skin appendages. J Pailwl 158:293-296, 1989
34. OrlofFJJ, Wu TL, Stewart AF: Parathyroid hormone-like protein: biochemical responses and receptor interactions. Endocr Re v 10:476-495, 1989
35. Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis \VJ, Stewart AF: Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide. N Eçl J .Med 117:261-271, 1988
36. Atillasoy EJ, Burtis \VJ, Milstone LM: Immunohistochemical localization of parathyroid hormone-related protein (PTHrP) in normal human skin. J Invest Dcnnatol 96:277-280, 1991
37. Merendino JJ, Insogna KL, Milstone LM, Broadus AE, Stewart AF: Cultured human keratinocytcs produce a parathyroid hormone-like protein. Science 231:388-390, 1986
38. Holick MF, Ray S, Chcn TC, Tian X, Persons K: A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in mice. Proc Xatl Acad Sci USA 91:8014-8016, 1994
39. Kaiser SM, Laneuville P, Bernicr SM, Rhim JS, Kremer R, Goltzman D: Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J Dial Chcm 267:13623-13628, 1992
40. Bikle DD, Pillai S: Vitamin D, calcium, and epidermal differentiation. Entlocr Rev 14:3-19, 1993